Invesco
LUCD icon

Invesco’s Lucid Diagnostics LUCD Stock Holding History

Invesco’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.6K Sell
37,926
-17
-0% -$22 ﹤0.01% 3704
2025
Q4 		$41.4K Buy
37,943
+592
+2% +$662 ﹤0.01% 3722
2025
Q3 		$37.7K Buy
37,351
+1,734
+5% +$1.89K ﹤0.01% 3759
2025
Q2 		$41K Buy
+35,617
New +$46K ﹤0.01% 3735
2022
Q1 		– Sell
-17,331
Closed -$93K – 4063
2021
Q4 		$93K Buy
+17,331
New +$141K ﹤0.01% 3913

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Invesco's LUCD Position: Q1 2026 in Review

Invesco reduced its Lucid Diagnostics (LUCD) stake by 0.04% in Q1 2026, selling an estimated $22 and leaving 37,926 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3704.

Invesco first reported a position in LUCD in Q4 2021 and has held it in 5 quarters since. The position peaked at $93K in Q4 2021. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Invesco held 37,926 shares of Lucid Diagnostics worth $43.6K as of Q1 2026.
  • Invesco sold 17 Lucid Diagnostics shares in Q1 2026, an estimated $22.
  • Lucid Diagnostics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3704 holding.
  • Invesco first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 5 quarters since.
  • Invesco's Lucid Diagnostics position peaked at $93K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.